88419-56-1

Basic information

• Product Name: 2,4,5-Trifluorobenzoyl chloride
• Synonyms: AKOS 91963;2,4,5-TRIFLUOROBENZOYL CHLORIDE;TIMTEC-BB SBB006657;Benzoyl chloride, 2,4,5-trifluoro- (9CI);2,4,5-Trifluorobenzoyl;2,4,5-Trifluorobenzoyl chloride 99%;2,4,5-Trifluorobenzoylchloride99%;2,4,5-Trifluorobenzoic acid chloride
• CAS NO: 88419-56-1
• Molecular Formula: C₇H₂ClF₃O
• Molecular Weight: 194.54
• Product Categories: ACIDHALIDE;Carbonyl Chlorides;Phenyls & Phenyl-Het;Miscellaneous;Carbonyl Chlorides;Phenyls & Phenyl-Het;Acid Halides;Carbonyl Compounds;Organic Building Blocks
• Mol File: 88419-56-1.mol
• Article Data: 39

Chemical Properties

• Boiling Point: 85°C 17mm
• Flash Point: 188 °F
• Appearance: Clear colorless/Liquid
• Density: 1.52 g/mL at 25 °C(lit.)
• Vapor Pressure: 1.25mmHg at 25°C
• Refractive Index: n20/D 1.498(lit.)
• Sensitive: Lachrymatory
• BRN: 3606259
• CAS DataBase Reference: 2,4,5-Trifluorobenzoyl chloride(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4,5-Trifluorobenzoyl chloride(88419-56-1)
• EPA Substance Registry System: 2,4,5-Trifluorobenzoyl chloride(88419-56-1)

Safety Data

• Hazard Codes: C
• Statements: 34
• Safety Statements: 26-36/37/39-45-25
• RIDADR: UN 3265 8/PG 2
• WGK Germany: 3
• F: 19-21
• HazardClass: 8
• PackingGroup: II
• Hazardous Substances Data: 88419-56-1(Hazardous Substances Data)

Usage

Chemical Properties

clear colorless liquid

InChI:InChI=1/C7H2ClF3O/c8-7(12)3-1-5(10)6(11)2-4(3)9/h1-2H

Upstream product

• 292621-58-0 3-chloro-2,4,5,6-tetrafluorobenzoyl chloride 
• 5360-81-6 3-chloro-2,4,5,6-tetrafluorobenzoic acid 
• 79-37-8 oxalyl dichloride 
• 446-17-3 2,4,5-trifluorobenzoic acid 
• 129322-83-4 2',4',5'-trifluoroacetophenone 
• 367-23-7 1,2,4-trifluorobenzene 
• 98349-22-5 2,4,5-trifluorobenzonitrile 
• 327-52-6 1-bromo-2,4,5-trifluorobenzene 

Downstream Products

• 1265764-17-7 2,4,5-trifluoro-N-(pyridin-3-yl)benzamide 
• 209995-38-0 (2,4,5-trifluorophenyl)acetic acid 
• 182875-05-4 tert-butyl 2,4,5-trifluorobenzoate 
• 780782-37-8 (+/-)-4-(dibenzylamino)-5-methyl-1-(2,4,5-trifluorophenyl)hex-2-yn-1-one 
• 98349-24-7 ethyl 2,4,5-trifluorobenzoylacetate 
• 675574-51-3 2,4,5-trifluoro-benzoic acid N'-(2,4-dichloro-5-fluoro-benzoyl)-hydrazide 
• 411231-67-9 3-benzoyl-2-benzyl-6,7-difluoro-1-propyl-1H-quinolin-4-one 
• 20372-66-1 methyl 2,4,5-trifluorobenzoate 
• 156152-89-5 phenyl 2,4,5-trifluorobenzoate 
• 104600-15-9 (2,4,5-trifluorobenzoyl)propanedioic acid, diethyl ester 

Relevant articles and documents

Synthesis and evaluation of 3-fluoro-2-piperazinyl-5,8,13-trihydro-5-oxoquino[1,2-a][3,1]benzoxazi ne-6-carboxylic acids as potential antibacterial agents

3-Fluoro-2-piperazinyl-5,8,13-trihydro-5-oxoquino[1,2-a][3,1]-benzoxaz zine-6-carboxylic acids were designed and synthesized as potential DNA gyrase inhibitors and antibacterial agents. The design rationale rests on the proposition made by Ohta and Koga that in order for N1-aryl substituted quinolones to possess antibacterial activity the N1-aryl ring should be oriented out of the plane of the quinolone ring. α-[Bis(methylthio)methylene)-2,4,5-trifluoro-β-oxobenzenepropanoic acid tert-butyl ester (6) obtained by the treatment of 2,4,5-trifluoro-β-oxobenzenepropanoic acid tert-butyl ester (5) with carbon disulfide and methyl iodide in the presence of cesium carbonate was used as a key intermediate, yielding tert-butyl 2,3-difluoro-5,8,13-trihydro-5-oxoquino[1,2-a][1,3]benzoxazine-6-carbo xylate (8) upon treatment with 2-aminobenzyl alcohol. The coupling of 8 with piperazines followed by the hydrolysis of the ester under acidic conditions afforded the desired product (3). Contrary to expectation, both compounds (3a,b) were, however, devoid of antibacterial activity, suggesting that for N1-aryl substituted quinolones to exhibit antimicrobial activity important structural feature(s) other than the conformational requirement of the N1-aryl ring with respect to the quinolone nucleus should also be satisfied.

HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING)

The present invention relates to compounds of formula (I) and salts, stereoisomers, tautomers or N-oxides thereof that are useful as modulators of STING (Stimulator of Interferon Genes). The present invention further relates to the compounds of formula (I) for use as a medicament and to a pharmaceutical composition comprising said compounds.

FUNCTIONALIZED HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING)

The present invention relates to compound-linker constructs and antibody-drug-conjugates of compounds of formula (I) that are useful as modulators of STING (Stimulator of Interferon Genes).

PROCESSES OF PREPARING A JAK1 INHIBITOR

The present application provides processes for preparing 4-[3-(cyanomethyl)-3-(3′,5′-dimethyl-1H, 1′H-4,4′-bipyrazol-1-yl)azetidin-1-yl]-2,5-difluoro-N-[(1S)-2,2,2-trifluoro-1-methylethyl]benzamide, and phosphoric acid salt thereof, which is useful as a selective (Janus kinase 1) JAK1 inhibitor, as well as salt forms and intermediates related thereto.